Journal article
Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner
- Abstract:
- Background: Cancer cells in severely hypoxic regions have been reported to invade towards tumour blood vessels after surviving radiotherapy in a postirradiation reoxygenation- and hypoxia-inducible factor (HIF)-dependent manner and cause recurrence. However, how HIF induces invasiveness of irradiated and reoxygenated cancer cells remains unclear. Methods: Here, we identified human minor histocompatibility antigen 1 (HMHA1), which has been suggested to function in cytoskeleton dynamics and cellular motility, as a responsible factor and elucidated its mechanism of action using molecular and cellular biology techniques. Results: HMHA1 expression was found to be induced at the transcription initiation level in a HIF-dependent manner under hypoxia. Boyden chamber invasion assay revealed that the induction of HMHA1 expression is required for the increase in invasion of hypoxic cancer cells. Reoxygenation treatment after ionising radiation in vitro that mimics dynamic changes of a microenvironment in hypoxic regions of tumour tissues after radiation therapy further enhanced HMHA1 expression and invasive potential of HMHA1 wildtype cancer cells in ROS- and HIF-dependent manners, but not of HMHA1 knockout cells. Conclusion: These results together provide insights into a potential molecular mechanism of the acquisition of invasiveness by hypoxic cancer cells after radiotherapy via the activation of the ROS/HIF/HMHA1 axis.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
(Preview, Version of record, pdf, 2.4MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41416-024-02691-x
Authors
+ Kobayashi Foundation for Cancer Research
More from this funder
- Funder identifier:
- https://ror.org/02qjq5342
+ Daiichi Sankyo Foundation of Life Science
More from this funder
- Funder identifier:
- https://ror.org/05j492n53
+ Foundation for Promotion of Cancer Research
More from this funder
- Funder identifier:
- https://ror.org/029aqdy80
+ Princess Takamatsu Cancer Research Fund
More from this funder
- Funder identifier:
- https://ror.org/00q3q5393
- Publisher:
- Springer Nature [academic journals on nature.com]
- Journal:
- British Journal of Cancer More from this journal
- Volume:
- 131
- Issue:
- 1
- Pages:
- 37-48
- Publication date:
- 2024-05-13
- Acceptance date:
- 2024-04-10
- DOI:
- EISSN:
-
1532-1827
- ISSN:
-
0007-0920
- Language:
-
English
- Pubs id:
-
1997973
- Local pid:
-
pubs:1997973
- Source identifiers:
-
2095659
- Deposit date:
-
2024-07-08
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
If you are the owner of this record, you can report an update to it here: Report update to this record